I was experiencing several side effects that the team on Excelmale helped me to identify. I was able to communicate with my doctor and he did respond with F/U blood draw (included most the items that Nelson recommended). The doc also perscribed Armidex (1 MG per week). I have been taking the Arimidex for (3) weeks (1 MG/wk) and it did reduce my sides. However, I was still not in the "zone". Then came the F/U blood work from last week (posted below). The doc said that he would be cutting back on the next test dose (currently using pellets). He also boosted the Arimidex to (2) MG for the next (2) weeks and then I'm to test again. The doc wants my estogens at 40 or below.
Please offer your thoughts and advice!
[TH="width: 35%"]Description[/TH] | |||||
[TD="colspan: 5"][/TD] | |||||
[TD="colspan: 6, align: left"]977709 - CBC/Diff Ambiguous Default[/TD] | |||||
WBC | 7.1 | x10E3/uL | 3.4-10.8 | F | |
RBC | 4.98 | x10E6/uL | 4.14-5.80 | F | |
Hemoglobin | 15.4 | g/dL | 12.6-17.7 | F | |
Hematocrit | 45.7 | % | 37.5-51.0 | F | |
MCV | 92 | fL | 79-97 | F | |
MCH | 30.9 | pg | 26.6-33.0 | F | |
MCHC | 33.7 | g/dL | 31.5-35.7 | F | |
RDW | 13.0 | % | 12.3-15.4 | F | |
Platelets | 318 | x10E3/uL | 155-379 | F | |
Neutrophils | 50 | % | 40-74 | F | |
Lymphs | 37 | % | 14-46 | F | |
Monocytes | 9 | % | 4-12 | F | |
Eos | 3 | % | 0-5 | F | |
Basos | 1 | % | 0-3 | F | |
Immature Cells | X | ||||
Neutrophils (Absolute) | 3.6 | x10E3/uL | 1.4-7.0 | F | |
Lymphs (Absolute) | 2.7 | x10E3/uL | 0.7-3.1 | F | |
Monocytes(Absolute) | 0.7 | x10E3/uL | 0.1-0.9 | F | |
Eos (Absolute) | 0.2 | x10E3/uL | 0.0-0.4 | F | |
Baso (Absolute) | 0.1 | x10E3/uL | 0.0-0.2 | F | |
Immature Granulocytes | 0 | % | 0-2 | F | |
Immature Grans (Abs) | 0.0 | x10E3/uL | 0.0-0.1 | F | |
NRBC | X | ||||
Hematology Comments: | X | ||||
[TD="colspan: 6"] | A hand-written panel/profile was received from your office. In[/TD] | ||||
[TD="colspan: 6"] | accordance with the LabCorp Ambiguous Test Code Policy dated July[/TD] | ||||
[TD="colspan: 6"] | 2003, we have assigned CBC with Differential/Platelet, Test Code[/TD] | ||||
[TD="colspan: 6"] | #005009 to this request. If this is not the testing you wished to[/TD] | ||||
[TD="colspan: 6"] | receive on this specimen, please contact the LabCorp Client Inquiry/[/TD] | ||||
[TD="colspan: 6"] | Technical Services Department to clarify the test order. We[/TD] | ||||
[TD="colspan: 6"] | appreciate your business.[/TD] | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]322000 - Comp. Metabolic Panel (14)[/TD] | |||||
Glucose, Serum | 92 | mg/dL | 65-99 | F | |
BUN | 12 | mg/dL | 6-24 | F | |
Creatinine, Serum | 1.30 | mg/dL | 0.76-1.27 | F | |
eGFR If NonAfricn Am | 62 | mL/min/1.73 | >59 | F | |
eGFR If Africn Am | 72 | mL/min/1.73 | >59 | F | |
BUN/Creatinine Ratio | 9 | 9-20 | F | ||
Sodium, Serum | 139 | mmol/L | 134-144 | F | |
Potassium, Serum | 3.9 | mmol/L | 3.5-5.2 | F | |
Chloride, Serum | 97 | mmol/L | 97-108 | F | |
Carbon Dioxide, Total | 28 | mmol/L | 19-28 | F | |
Calcium, Serum | 9.6 | mg/dL | 8.7-10.2 | F | |
Protein, Total, Serum | 6.8 | g/dL | 6.0-8.5 | F | |
Albumin, Serum | 4.6 | g/dL | 3.5-5.5 | F | |
Globulin, Total | 2.2 | g/dL | 1.5-4.5 | F | |
A/G Ratio | 2.1 | 1.1-2.5 | F | ||
Bilirubin, Total | 0.4 | mg/dL | 0.0-1.2 | F | |
Alkaline Phosphatase, S | 74 | IU/L | 39-117 | F | |
AST (SGOT) | 33 | IU/L | 0-40 | F | |
ALT (SGPT) | 22 | IU/L | 0-44 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]140103 - Testosterone,Free and Total[/TD] | |||||
Testosterone, Serum | >1500 | ng/dL | 348-1197 | F | |
Free Testosterone(Direct) | 41.4 | pg/mL | 7.2-24.0 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]010322 - Prostate-Specific Ag, Serum[/TD] | |||||
Prostate Specific Ag, Serum | 1.7 | ng/mL | 0.0-4.0 | F | |
[TD="colspan: 6"] | Roche ECLIA methodology.[/TD] | ||||
[TD="colspan: 6"] | .[/TD] | ||||
[TD="colspan: 6"] | According to the American Urological Association, Serum PSA should[/TD] | ||||
[TD="colspan: 6"] | decrease and remain at undetectable levels after radical[/TD] | ||||
[TD="colspan: 6"] | prostatectomy. The AUA defines biochemical recurrence as an initial[/TD] | ||||
[TD="colspan: 6"] | PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory[/TD] | ||||
[TD="colspan: 6"] | PSA value 0.2 ng/mL or greater.[/TD] | ||||
[TD="colspan: 6"] | Values obtained with different assay methods or kits cannot be used[/TD] | ||||
[TD="colspan: 6"] | interchangeably. Results cannot be interpreted as absolute evidence[/TD] | ||||
[TD="colspan: 6"] | of the presence or absence of malignant disease.[/TD] | ||||
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]004549 - Estrogens, Total[/TD] | |||||
Estrogens, Total | 86 | pg/mL | 40-115 | F | |
[TD="colspan: 6"][/TD] | |||||
[TD="colspan: 6, align: left"]977206 - Ambig Abbrev CMP14 Default[/TD] | |||||
Ambig Abbrev CMP14 Default | F | ||||
[TD="colspan: 6"] | A hand-written panel/profile was received from your office. In[/TD] | ||||
[TD="colspan: 6"] | accordance with the LabCorp Ambiguous Test Code Policy dated July[/TD] | ||||
[TD="colspan: 6"] | 2003, we have completed your order by using the closest currently[/TD] | ||||
[TD="colspan: 6"] | or formerly recognized AMA panel. We have assigned Comprehensive[/TD] | ||||
[TD="colspan: 6"] | Metabolic Panel (14), Test Code #322000 to this request. If this[/TD] | ||||
[TD="colspan: 6"] | is not the testing you wished to receive on this specimen, please[/TD] | ||||
[TD="colspan: 6"] | contact the LabCorp Client Inquiry/Technical Services Department[/TD] | ||||
[TD="colspan: 6"] | to clarify the test order. We appreciate your business.[/TD] |
